A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfapyridine
Amediplase
The risk or severity of angioedema can be increased when Spirapril is combined with Amediplase.
Sulfapyridine
Saxagliptin
The risk or severity of angioedema can be increased when Spirapril is combined with Saxagliptin.
Sulfapyridine
Temsirolimus
The risk or severity of angioedema can be increased when Spirapril is combined with Temsirolimus.
Sulfapyridine
Lanoteplase
The risk or severity of angioedema can be increased when Spirapril is combined with Lanoteplase.
Sulfapyridine
Alogliptin
The risk or severity of angioedema can be increased when Spirapril is combined with Alogliptin.
Sulfapyridine
Bisegliptin
The risk or severity of angioedema can be increased when Spirapril is combined with Bisegliptin.
Sulfapyridine
AMG-222
The risk or severity of angioedema can be increased when Spirapril is combined with AMG-222.
Sulfapyridine
Vildagliptin
The risk or severity of angioedema can be increased when Spirapril is combined with Vildagliptin.
Sulfapyridine
Rescinnamine
The risk or severity of angioedema can be increased when Rescinnamine is combined with Spirapril.
Sulfapyridine
Patent Blue
The risk or severity of adverse effects can be increased when Spirapril is combined with Patent Blue.
Sulfapyridine
Iron Dextran
The risk or severity of adverse effects can be increased when Spirapril is combined with Iron Dextran.
Sulfapyridine
Barnidipine
Spirapril may increase the antihypertensive activities of Barnidipine.
Sulfapyridine
Candesartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Candesartan.
Sulfapyridine
Fimasartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Fimasartan.
Sulfapyridine
Azilsartan medoxomil
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Azilsartan medoxomil.
Sulfapyridine
Saralasin
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Saralasin.
Sulfapyridine
Tasosartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Tasosartan.
Sulfapyridine
Saprisartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Saprisartan.
Sulfapyridine
Forasartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Forasartan.
Sulfapyridine
Irbesartan
The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Spirapril is combined with Irbesartan.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3